Detalhe da pesquisa
1.
Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies.
FASEB J
; 34(4): 5851-5862, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32141122
2.
Cell surface nucleolin as active bait for nanomedicine in cancer therapy: a promising option.
Nanotechnology
; 32(32)2021 May 17.
Artigo
Inglês
| MEDLINE | ID: mdl-33892482
3.
Weibel-Palade Bodies Orchestrate Pericytes During Angiogenesis.
Arterioscler Thromb Vasc Biol
; 39(9): 1843-1858, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31315435
4.
Polymerization-Induced Self-Assembly (PISA) for in situ drug encapsulation or drug conjugation in cancer application.
J Colloid Interface Sci
; 618: 173-184, 2022 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35338924
5.
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.
Cancers (Basel)
; 14(17)2022 Aug 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36077801
6.
Correction: Ponzo et al. Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression. Cancers 2022, 14, 4265.
Cancers (Basel)
; 14(24)2022 Dec 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36551754
7.
Nucleolin Targeting by N6L Inhibits Wnt/ß-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma.
Cancers (Basel)
; 13(12)2021 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34203710
8.
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapy.
Oncotarget
; 8(52): 90108-90122, 2017 Oct 27.
Artigo
Inglês
| MEDLINE | ID: mdl-29163814
9.
Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature.
Cancer Res
; 76(24): 7181-7193, 2016 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27754848